ETON News and Press, Eton Pharmaceutcials Inc.

DEER PARK, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report four...

HEMANGEOL® is the only FDA-approved treatment for infantile hemangioma HEMANGEOL will be commercialized by Eton beginning May 1 st HEMANGEOL will be distributed through the company’s Eton Cares™ patient support program, which includes a $0 co-pay initiative, to broaden patie...

2026-02-25 14:20:20 ET More on Eton Pharmaceuticals Eton Pharmaceuticals: An Undervalued Small Cap With High Growth Seeking Alpha’s Quant Rating on Eton Pharmaceuticals Historical earnings data for Eton Pharmaceuticals Financial information for Eton Ph...

DESMODA is the first and only FDA-approved desmopressin oral solution Commercial launch expected on March 9 th DESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing for patients of all ages The product is expected to be a significant long-term growth contri...

2026-02-20 15:00:23 ET More on the markets VT: Still The Best Approach To Passive Investing U.S. GDP Set To Bounce Back After Government Shutdown Depresses Q4 Activity Why Static Portfolios Fail When Risk Regimes Change Trump says shutdown cut “at leas...

DEER PARK, Ill., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Compa...

Product is currently under review with the FDA Potential approval and launch mid-2026 DEER PARK, Ill., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing a...

2026-01-23 10:20:07 ET Article Thesis I wrote about ETON Pharmaceuticals ( ETON ) at the beginning of August. I liked this company (and still do) because: They acquire ultra-rare disease drugs (aided by some internal development) at very low prices, and these are alrea...

2026-01-05 16:15:00 ET Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry's major underlying drivers — higher rates of cancer and chronic di...

2025-11-25 17:30:02 ET Background I am a retired engineer. I have a diversified portfolio composed of equity funds, individual stocks, bond funds and individual stocks. I invest in bonds and dividend stocks to provide the cash flow required to fund my retirement. That said, ...